
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.680 | 1.740 | 0.060 |
Shares | 97.330 | 97.330 | 0.000 |
Bonds | 0.990 | 0.990 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 39.352 | 24.212 |
Price to Book | 11.269 | 5.252 |
Price to Sales | 9.355 | 3.739 |
Price to Cash Flow | 25.082 | 15.865 |
Dividend Yield | 0.340 | 1.457 |
5 Years Earnings Growth | 11.470 | 10.150 |
Name | Net % | Category Average |
---|---|---|
Technology | 47.900 | 33.877 |
Communication Services | 23.590 | 10.948 |
Healthcare | 13.800 | 11.760 |
Consumer Cyclical | 8.630 | 11.978 |
Financial Services | 6.080 | 12.855 |
Number of long holdings: 16
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Netflix | US64110L1061 | 8.65 | 1,158.60 | -0.07% | |
Meta Platforms | US30303M1027 | 8.49 | 750.01 | -3.03% | |
Amazon.com | US0231351067 | 8.40 | 214.75 | -8.27% | |
CrowdStrike Holdings | US22788C1053 | 8.28 | 446.66 | -1.74% | |
Microsoft | US5949181045 | 8.19 | 524.11 | -1.76% | |
NVIDIA | US67066G1040 | 8.16 | 173.72 | -2.33% | |
Eli Lilly | US5324571083 | 7.89 | 762.33 | +3.01% | |
Visa A | US92826C8394 | 5.91 | 339.35 | -1.77% | |
Alphabet C | US02079K1079 | 5.82 | 189.95 | -1.51% | |
Palantir | US69608A1088 | 5.67 | 154.27 | -2.58% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CI Fondo A | 1.92B | -2.09 | 29.74 | - | ||
CI Fondo BF-3 | 1.92B | -3.24 | 26.68 | - | ||
CI Fondo BF-4 | 1.92B | -3.52 | 25.94 | - | ||
CI Crecimiento A | 14.12M | 16.37 | 12.37 | 6.01 | ||
CI Fondos SA de CV SIID BF-4 | 14.12M | 14.45 | 8.89 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review